Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. | Director | Common Stock | 782K | $16.3M | $20.81 | Jan 7, 2025 | Indirect |
Denali Therapeutics Inc. | Director | Common Stock | 25.8K | $536K | $20.81 | Jan 7, 2025 | Direct |
Guardant Health, Inc. | Director | Common Stock | 10.7K | $454K | $42.47 | Mar 31, 2025 | Direct |
PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 53.5K | $111K | $2.08 | Jun 13, 2024 | Direct |
Guardant Health, Inc. | Director | Restricted Stock Units | 2.32K | $98.3K | $42.47 | Mar 31, 2025 | Direct |
Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 51.8K | Jun 16, 2023 | Direct | ||
Denali Therapeutics Inc. | Director | Stock Option (right to buy) | 17.9K | May 31, 2024 | Direct | ||
Guardant Health, Inc. | Director | Stock Option (Right to Buy) | 10.7K | Jun 12, 2024 | Direct |